Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery

Columbia University Medical Center, New York

"Azienda Sanitaria Ospedaliera San Giovanni Battista, Cardiac Surgery Division", Torino

Montefiore Medical Center/Albert Einstein College of Medicine, New York

University of Virginia Health System, Charlottesville

Fondazione IRCCS San Matteo Hospital, Cardiac Surgery, Pavia

Wake Forest University Health Sciences, Winston-Salem

Duke University Medical Center, Durham

The Cleveland Clinic, Cleveland

Baylor University Medical Center, Dallas

Texas Heart Institute/St. Luke's Episcopal Hospital/Baylor College, Houston

Stanford University School of Medicine, Stanford

Medical University of Innsbruck, Innsbruck

AKH University of Vienna, Vienna

Institute for Clinical and Experimental Medicine (IKEM), Prague

Hopital Pitie Salpetriere, Paris

Deutches Herzzentrum, Berlin

Dresden Universitatsklinik/Cardiology Center, Dresden

Narayana Hrudayalaya, Bangalore

Nizam's Institute of Medical Sciences, Hyderabaad

Shaare Zedek Medical Center, Jerusalem

Medical University of Silesia, 2nd Dept of Cardiac Surgery, Katowice

Dedinje Cardiovascular Institute, Belgrade

National Institute of Cardiovascular Diseases, Clinic of Heart Surgery, Bratislava

Sahlgrenska University Hospital, Gothenburg

Papworth Hospital, Cambridge

Northern General Hospital, Sheffield

University of Alberta Hospital, Edmonton

London Health Sciences Centre-University Hospital, London

Toronto General Hospital, Toronto

Montreal Heart Institute, Montreal

Quebec Heart Institute/Hopital Laval, Québec

Zentrum der Chirugie-Zchir-des Universitatsklinikums, Frankfurt

Klinika Chirurgii Serca, Naczyn I Transplantologii, Szpital Jana Pawla II, Krakow